A new Korean Research Investment for Global Health Technology (RIGHT) Fund to advance innovative neglected-disease technologies

In 2018, the government of the Republic of Korea (ROK), South Korean life science companies, and a group of international funders led by the Bill & Melinda Gates Foundation launched a new and innovative funding agency to support neglected-disease research and development (R&D). The new ventu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hotez, Peter J., Bush, Kim, Oswald, Andrin, Rockman, Glenn, Lim, In-taek, Jee, Youngmee, Moon, Chang Jin, Kim, Jerome H., Kim, Younbeen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470318/
https://www.ncbi.nlm.nih.gov/pubmed/32881862
http://dx.doi.org/10.1371/journal.pntd.0007956
Descripción
Sumario:In 2018, the government of the Republic of Korea (ROK), South Korean life science companies, and a group of international funders led by the Bill & Melinda Gates Foundation launched a new and innovative funding agency to support neglected-disease research and development (R&D). The new venture is known as the Research Investment for Global Health Technology (RIGHT) Fund.

Ejemplares similares